Mettine H A Bos Selected Research

Thrombophilia

12/2023	The interplay between tamoxifen and endoxifen plasma concentrations and coagulation parameters in patients with primary breast cancer.
12/2020	Association Between Hepatic Triglyceride Content and Coagulation Factors: The Netherlands Epidemiology of Obesity Study.
1/2019	Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mettine H A Bos Research Topics

Disease

9	Hemorrhage 05/2024 - 01/2016
5	Venous Thromboembolism 05/2024 - 12/2018
5	Thrombosis (Thrombus) 01/2021 - 01/2010
3	Thrombophilia 12/2023 - 01/2019
2	Atrial Fibrillation 05/2024 - 11/2020
2	Hemophilia A (Haemophilia) 01/2023 - 01/2023
2	Neoplasms (Cancer) 01/2022 - 06/2021
2	Hemophilia B (Haemophilia B) 01/2020 - 12/2019
2	Venous Thrombosis (Deep-Vein Thrombosis) 04/2018 - 01/2017
1	Breast Neoplasms (Breast Cancer) 12/2023
1	Leg Injuries (Leg Injury) 01/2022
1	Stroke (Strokes) 01/2022
1	Melanoma (Melanoma, Malignant) 06/2021
1	Obesity 12/2020
1	Bites and Stings (Sting) 11/2019
1	Snake Bites (Snake Bite) 08/2019
1	Liver Diseases (Liver Disease) 04/2018

Drug/Important Bio-Agent (IBA)

7	Vitamin K FDA Link 05/2024 - 01/2016
5	AnticoagulantsIBA 05/2024 - 01/2017
4	Thrombin FDA Link 01/2022 - 01/2010
3	Factor Xa (Coagulation Factor Xa)IBA 01/2022 - 01/2017
3	Blood Coagulation Factors (Coagulation Factor)IBA 12/2020 - 01/2017
3	Prothrombin (Factor II)IBA 11/2020 - 01/2010
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 05/2024 - 04/2018
2	Factor Xa InhibitorsIBA 05/2024 - 01/2017
2	EnzymesIBA 04/2024 - 01/2010
2	Viper Venoms (Viper Venom)IBA 01/2023 - 06/2021
2	Factor V (Coagulation Factor V)IBA 01/2022 - 04/2018
2	VenomsIBA 06/2021 - 11/2019
2	Hemostatics (Antihemorrhagics)IBA 01/2021 - 01/2017
1	apixabanIBA 05/2024
1	Factor X (Stuart Factor)IBA 05/2024
1	glutamyl carboxylase (gamma-glutamyl carboxylase)IBA 04/2024
1	Cytochrome P-450 CYP2C9IBA 04/2024
1	Vitamin K Epoxide ReductasesIBA 04/2024
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 04/2024
1	Tamoxifen FDA LinkGeneric 12/2023
1	4-hydroxy-N-desmethyltamoxifenIBA 12/2023
1	Factor VIII (Coagulation Factor VIII)IBA 01/2023
1	A-factor (Streptomyces)IBA 01/2023
1	Oral ContraceptivesIBA 01/2022
1	CoagulantsIBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	Snake Venoms (Snake Venom)IBA 06/2021
1	ThrombomodulinIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 12/2020
1	recombinant FVIIa (rFVIIa)FDA Link 11/2020
1	Antivenins (Antivenoms)IBA 08/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2019
1	AntithrombinsIBA 12/2018
1	factor V LeidenIBA 04/2018
1	ORALIT (ORS)IBA 04/2018
1	Apolipoproteins B (ApoB)IBA 01/2017
1	LipidsIBA 01/2017
1	C-Reactive ProteinIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 07/2010
1	Thromboplastin (Tissue Factor)IBA 01/2010

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2019
1	Off-Label Use 11/2020